Rejected at 9:12 p.m. Oct, 31, 2023 ] by Alex
Author: learnwell
Related Note: 1488847733019 1
Rationale for change

If we look at sketchy below, its supposed to be P2Y12 receptors that clopidogrel works on ... not gb2/3 ... unless the info in this card has nothing to do with related images?

Rejection reason

amboss agrees with other comment

Text Text
Sketchy Sketchy
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::06_Antiplatelets::*ADP_receptor_Inhibitors #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::03_Mixing_Studies,_Ristocetin,_and_D-dimer #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::04_Antiplatelet_Drugs::Extra #AK_Step2_v12::#SketchyIM::01_Cardiology::01_Ischemic_Heart_Disease::09_Post_ACS_Management #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::02_Bleeding_Disorders:_Platelet_Disorders_DDx #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::06_ADP_Receptor_Inhibitors #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::05_Antiplatelet_Medications #AK_Step2_v12::#B&B::02_Cardio::02_Ischemic_Heart_Disease::02_STEMI::Extra #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::02_Platelet_Activation #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::06_Antiplatelet_Drugs::Extra #AK_Step1_v12::#AMBOSS::T-069i #AK_Step1_v12::#UWorld::COMLEX::24937 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::04_Thrombogenesis #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::08_Glycoprotein_IIb/IIIa_Inhibitors #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#UWorld::Step::1828 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents